bs-1264R-BF594 [Conjugated Primary Antibody]
RSV Polyclonal Antibody, AbBy Fluor® 594 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: RSV

Immunogen Range: 151-250/298


Clonality: Polyclonal

Isotype: IgG

Swiss Prot: P03423

Source: KLH conjugated synthetic peptide derived from Human respiratory syncytial virus A2 major surface glycoprotein G

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children. RSV infection produces a variety of signs and symptoms involving different areas of the respiratory tract, from the nose to the lungs. RSV is a negative sense, enveloped RNA virus. The virion is variable in shape and size with average diameter of between 120 and 300 nm. The 63 kD RSV fusion protein of the RSS 2 strain (subtype A) directs fusion of viral and cellular membranes, results in viral penetration, and can direct fusion of infected cells with adjoining cells, resulting in the formation of syncytia or multi nucleated giant cells.

Conjugation: AbBy Fluor® 594

Excitation/ Emission: 590nm/617nm

Size: 100ul

Concentration: 1ug/ul

Applications: IF(IHC-P)(1:500-1000)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 33


Cross Reactive Species: Human
Virus
(HRSVA)

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Pei Dai. et al. The dispersion and utilization of lipid droplets mediates respiratory syncytial virus-induced airway hyperresponsiveness. 2021 Aug 12Read more>>
  • Liu Dan. et al. RSV Promotes Epithelial Neuroendocrine Phenotype Differentiation through NODAL Signaling Pathway. Biomed Res Int. 2021;2021:9956078Read more>>
  • Yu Mao. et al. Lung-brain axis: Metabolomics and Pathological changes in lungs and brain of Respiratory syncytial virus infected mice. J MED VIROL. 2022 AugRead more>>
  • Dai Pei. et al. The antiviral efficacies of small-molecule inhibitors against respiratory syncytial virus based on the F protein. J ANTIMICROB CHEMOTH. 2022 NovRead more>>
  • Pei Dai. et al. Gimap5 promoted RSV degradation through interaction with M6PR. J MED VIROL. 2022 DecRead more>>
  • Dan Liu. et al. miR-34b/c-5p/CXCL10 Axis Induced by RSV Infection Mediates a Mechanism of Airway Hyperresponsive Diseases. BIOLOGY-BASEL. 2023 Feb;12(2):317Read more>>
  • Ousman Bajinka. et al. Respiratory syncytial virus infection disrupts pulmonary microbiota to induce microglia phenotype shift. J MED VIROL. 2023 Jul;95(8):e28976Read more>>
  • Pinglang Ruan. et al. The in?vitro and in?vivo antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection. J BIOMOL STRUCT DYN. 2024 Feb 01Read more>>